Authors: de Rie, MA de Hoop, D Jonsson, L Bakkers, EJM Sorensen, M

Citation: Ma. De Rie et al., Pharmacoeconomic evaluation of calcipotriol (Daivonex (R)/Dovonex (R)) andUVB phototherapy in the treatment of psoriasis: A Markov model for the Netherlands, DERMATOLOGY, 202(1), 2001, pp. 38-43

Authors: de Rie, MA Bos, JD

Citation: Ma. De Rie et Jd. Bos, Photochemotherapy for systemic and localized scleroderma, J AM ACAD D, 43(4), 2000, pp. 725-726

Authors: Di Nuzzo, S Sylva-Steenland, RMR Koomen, CW de Rie, MA Das, PK Bos, JD Teunissen, MBM

Citation: S. Di Nuzzo et al., Exposure to UVB induces accumulation of LFA-1(+) T cells and enhanced expression of the chemokine psoriasin in normal human skin, PHOTOCHEM P, 72(3), 2000, pp. 374-382

Authors: de Rie, MA

Citation: Ma. De Rie, Interleukin 12 and psoriasis, DERMATOLOGY, 199(2), 1999, pp. 101-101

Authors: Enomoto, DNH Mekkes, JR Bossuyt, PMM Yong, SL Out, TA Hoekzema, R de Rie, MA Schellekens, PTA ten Berge, IJM de Borgie, CAJM Bos, JD

Citation: Dnh. Enomoto et al., Treatment of patients with systemic sclerosis with extracorporeal photochemotherapy (photopheresis), J AM ACAD D, 41(6), 1999, pp. 915-922

Authors: Brands, S Brakman, M Bos, JD de Rie, MA

Citation: S. Brands et al., No additional effect of calcipotriol ointment on low-dose narrow-band UVB phototherapy in psoriasis, J AM ACAD D, 41(6), 1999, pp. 991-995